Sex differences in influenza virus infection, vaccination, and therapies

Jackye Peretz, Olivia J. Hall, Sabra L Klein

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Males and females differ in the likely outcome of influenza virus infection and vaccination. Following infection with pandemic and outbreak strains of influenza viruses, females of reproductive ages (15-49 years of age) experience a worse outcome than their male counterparts. Among females of reproductive ages, pregnancy is one factor linked to an increased risk of severe outcome of influenza, although it is not the sole factor explaining the female preponderance of severe disease. The sex bias in disease outcome is reversed in children under the age of 10 years and adults over the age of 65 years, where males appear to be more likely to be hospitalized or die from influenza. Small animal models of influenza virus infection illustrate that inflammatory immune responses also differ between the sexes and impact the outcome of infection. Males and females also generally respond differently to influenza vaccines and antiviral treatments, with females on average initiating higher humoral immune responses following vaccination and experiencing more adverse reactions to vaccines and drug treatments than males. Small animal models further show that elevated immunity following vaccination in females compared with males leads to greater cross protection against novel influenza viruses. We hypothesize that sex steroid hormones, including estrogens, progesterone, and androgens, as well as genetic differences between the sexes, may play roles in modulating sex differences in immune responses to influenza virus infection and vaccination.

Original languageEnglish (US)
Title of host publicationSex and Gender Differences in Infection and Treatments for Infectious Diseases
PublisherSpringer International Publishing
Pages183-210
Number of pages28
ISBN (Print)9783319164380, 9783319164373
DOIs
StatePublished - Aug 8 2015

Fingerprint

Virus Diseases
Orthomyxoviridae
Sex Characteristics
Vaccination
Human Influenza
Therapeutics
Animal Models
Cross Protection
Sexism
Influenza Vaccines
Gonadal Steroid Hormones
Pandemics
Humoral Immunity
Infection
Androgens
Antiviral Agents
Disease Outbreaks
Progesterone
Immunity
Estrogens

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Peretz, J., Hall, O. J., & Klein, S. L. (2015). Sex differences in influenza virus infection, vaccination, and therapies. In Sex and Gender Differences in Infection and Treatments for Infectious Diseases (pp. 183-210). Springer International Publishing. https://doi.org/10.1007/978-3-319-16438-0_6

Sex differences in influenza virus infection, vaccination, and therapies. / Peretz, Jackye; Hall, Olivia J.; Klein, Sabra L.

Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Springer International Publishing, 2015. p. 183-210.

Research output: Chapter in Book/Report/Conference proceedingChapter

Peretz, J, Hall, OJ & Klein, SL 2015, Sex differences in influenza virus infection, vaccination, and therapies. in Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Springer International Publishing, pp. 183-210. https://doi.org/10.1007/978-3-319-16438-0_6
Peretz J, Hall OJ, Klein SL. Sex differences in influenza virus infection, vaccination, and therapies. In Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Springer International Publishing. 2015. p. 183-210 https://doi.org/10.1007/978-3-319-16438-0_6
Peretz, Jackye ; Hall, Olivia J. ; Klein, Sabra L. / Sex differences in influenza virus infection, vaccination, and therapies. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Springer International Publishing, 2015. pp. 183-210
@inbook{e5a78185c3f641e19ca193465d8ceeee,
title = "Sex differences in influenza virus infection, vaccination, and therapies",
abstract = "Males and females differ in the likely outcome of influenza virus infection and vaccination. Following infection with pandemic and outbreak strains of influenza viruses, females of reproductive ages (15-49 years of age) experience a worse outcome than their male counterparts. Among females of reproductive ages, pregnancy is one factor linked to an increased risk of severe outcome of influenza, although it is not the sole factor explaining the female preponderance of severe disease. The sex bias in disease outcome is reversed in children under the age of 10 years and adults over the age of 65 years, where males appear to be more likely to be hospitalized or die from influenza. Small animal models of influenza virus infection illustrate that inflammatory immune responses also differ between the sexes and impact the outcome of infection. Males and females also generally respond differently to influenza vaccines and antiviral treatments, with females on average initiating higher humoral immune responses following vaccination and experiencing more adverse reactions to vaccines and drug treatments than males. Small animal models further show that elevated immunity following vaccination in females compared with males leads to greater cross protection against novel influenza viruses. We hypothesize that sex steroid hormones, including estrogens, progesterone, and androgens, as well as genetic differences between the sexes, may play roles in modulating sex differences in immune responses to influenza virus infection and vaccination.",
author = "Jackye Peretz and Hall, {Olivia J.} and Klein, {Sabra L}",
year = "2015",
month = "8",
day = "8",
doi = "10.1007/978-3-319-16438-0_6",
language = "English (US)",
isbn = "9783319164380",
pages = "183--210",
booktitle = "Sex and Gender Differences in Infection and Treatments for Infectious Diseases",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Sex differences in influenza virus infection, vaccination, and therapies

AU - Peretz, Jackye

AU - Hall, Olivia J.

AU - Klein, Sabra L

PY - 2015/8/8

Y1 - 2015/8/8

N2 - Males and females differ in the likely outcome of influenza virus infection and vaccination. Following infection with pandemic and outbreak strains of influenza viruses, females of reproductive ages (15-49 years of age) experience a worse outcome than their male counterparts. Among females of reproductive ages, pregnancy is one factor linked to an increased risk of severe outcome of influenza, although it is not the sole factor explaining the female preponderance of severe disease. The sex bias in disease outcome is reversed in children under the age of 10 years and adults over the age of 65 years, where males appear to be more likely to be hospitalized or die from influenza. Small animal models of influenza virus infection illustrate that inflammatory immune responses also differ between the sexes and impact the outcome of infection. Males and females also generally respond differently to influenza vaccines and antiviral treatments, with females on average initiating higher humoral immune responses following vaccination and experiencing more adverse reactions to vaccines and drug treatments than males. Small animal models further show that elevated immunity following vaccination in females compared with males leads to greater cross protection against novel influenza viruses. We hypothesize that sex steroid hormones, including estrogens, progesterone, and androgens, as well as genetic differences between the sexes, may play roles in modulating sex differences in immune responses to influenza virus infection and vaccination.

AB - Males and females differ in the likely outcome of influenza virus infection and vaccination. Following infection with pandemic and outbreak strains of influenza viruses, females of reproductive ages (15-49 years of age) experience a worse outcome than their male counterparts. Among females of reproductive ages, pregnancy is one factor linked to an increased risk of severe outcome of influenza, although it is not the sole factor explaining the female preponderance of severe disease. The sex bias in disease outcome is reversed in children under the age of 10 years and adults over the age of 65 years, where males appear to be more likely to be hospitalized or die from influenza. Small animal models of influenza virus infection illustrate that inflammatory immune responses also differ between the sexes and impact the outcome of infection. Males and females also generally respond differently to influenza vaccines and antiviral treatments, with females on average initiating higher humoral immune responses following vaccination and experiencing more adverse reactions to vaccines and drug treatments than males. Small animal models further show that elevated immunity following vaccination in females compared with males leads to greater cross protection against novel influenza viruses. We hypothesize that sex steroid hormones, including estrogens, progesterone, and androgens, as well as genetic differences between the sexes, may play roles in modulating sex differences in immune responses to influenza virus infection and vaccination.

UR - http://www.scopus.com/inward/record.url?scp=84955718502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955718502&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-16438-0_6

DO - 10.1007/978-3-319-16438-0_6

M3 - Chapter

AN - SCOPUS:84955718502

SN - 9783319164380

SN - 9783319164373

SP - 183

EP - 210

BT - Sex and Gender Differences in Infection and Treatments for Infectious Diseases

PB - Springer International Publishing

ER -